Given the fact that 60–80% of lung cancer tissues harbor p53 mutations, and Sesn1 and Sesn2 are direct targets of p53 mediated transcription, the role of Sesns in tumor genesis may be part of a mechanism underlying the impairment of p53 in lung cancer cells. This evidence concerns the gene SESN2 and neoplasm.